HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yongbiao Chen Selected Research

Hepatocellular Carcinoma (Hepatoma)

10/2023Upregulation of lncRNA PTOV1-AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR-505.
1/2023Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospective, single-arm, single-center clinical study.
12/2021Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.
1/2020microR-505/heterogeneous nuclear ribonucleoprotein M inhibits hepatocellular carcinoma cell proliferation and induces cell apoptosis through the Wnt/β-catenin signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yongbiao Chen Research Topics

Disease

4Neoplasms (Cancer)
10/2023 - 03/2020
4Hepatocellular Carcinoma (Hepatoma)
10/2023 - 01/2020
2Ischemia
01/2021 - 11/2016
2Cholestasis
10/2020 - 01/2013
1Carcinogenesis
10/2023
1Disease Progression
10/2023
1Liver Failure
10/2020
1Liver Cirrhosis (Hepatic Cirrhosis)
10/2020
1Lung Neoplasms (Lung Cancer)
03/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2020
1Neoplasm Metastasis (Metastasis)
01/2020
1Pathologic Processes
11/2019
1Extrahepatic Cholestasis
01/2013

Drug/Important Bio-Agent (IBA)

3MicroRNAs (MicroRNA)IBA
10/2023 - 11/2019
2Bile Acids and Salts (Bile Acids)IBA
10/2020 - 01/2013
2Glycochenodeoxycholic Acid (Glycochenodeoxycholate)IBA
10/2020 - 01/2013
1Long Noncoding RNAIBA
10/2023
1Sorafenib (BAY 43-9006)FDA Link
10/2023
1anlotinibIBA
01/2023
1toripalimabIBA
01/2023
1AntigensIBA
01/2023
1Interleukin-2 (IL2)IBA
03/2020
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
03/2020
1Heterogeneous-Nuclear Ribonucleoprotein Group MIBA
01/2020
1CateninsIBA
01/2020
1dihydromyricetinIBA
11/2016

Therapy/Procedure

1Aftercare (After-Treatment)
10/2023
1Liver Transplantation
01/2021